AnaptysBio, Inc.
10421 Pacific Center Court
Suite 200
San Diego
California
92121
United States
Tel: 858-362-6295
Fax: 858-362-6296
Website: http://www.anaptysbio.com/
Email: info@anaptysbio.com
About AnaptysBio, Inc.
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation. We develop our product candidates to address emerging biological targets using our proprietary antibody discovery technology platform, which is based upon a breakthrough understanding of the natural process of antibody generation, known as somatic hypermutation, or SHM, and replicates this natural process of antibody generation in vitro. Our strategy is to advance the development and commercialization of our proprietary product candidates, and for certain programs, establish partnerships with leading biopharmaceutical companies where we retain certain development and commercialization rights in the United States.
Our wholly-owned product pipeline includes etokimab (ANB020) and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. We are advancing etokimab, our proprietary anti-interleukin-33 antibody, for the treatment of atopic dermatitis, eosinophilic asthma and chronic rhinosinusitis with nasal polyps.
In addition, we are developing our ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustulosis (PPP).
Our company is led by a strong management team with a proven track record of successfully growing biotechnology companies with deep experience in antibody discovery and development, collaborations, operations and corporate finance.
Additionally, multiple AnaptysBio-generated antibodies have entered the clinic under our immuno-oncology-focused collaboration with TESARO and inflammation-focused collaboration with Celgene.
Stock Exchange: NASDAQ
Stock Symbol: ANAB
11 jobs with AnaptysBio, Inc.
-
Executive Director, Medical Development (2)
The Executive Director, Medical Development is responsible for the design, plan and execution of clinical trials, and running of programs focused on a
-
Sr. Research Associate
Anaptysbio has a new opportunity for a Senior Research Associate to join the Protein Sciences group to support antibody discovery and biophysical char
-
Associate Director, Downstream Process Development
AnaptysBio is seeking an Associate Director to manage antibody downstream process development and technical transfer activities supporting all stages
-
Associate Director, Project Manager, CMC Biologics
Position SummaryThe candidate in this position is responsible for providing chemistry, manufacturing and control (CMC) project management for one or m
-
Associate Director/Director, Upstream Process Development
This position is responsible for leading the upstream process development and subsequent manufacturing of biological products at contract manufacturin
-
-
CMC (Biologics Manufacturing) Project Manager
The Project Manager is responsible for providing chemistry, manufacturing and control (CMC) project management for one or more of AnaptysBio's novel t
-
Facilities Manager
The Facilities Manager plays a key role ensuring all facilities and equipment support the Company's operations. This person oversees the daily operati
-
Quality Systems Manager
We are seeking a Quality Systems Manager to establish our quality systems, processes, and procedures to ensure compliance with regulations. The manage
-
Clinical Supply Manager
Position SummaryThe Sr. Project Manager, Clinical Supply, is responsible for managing the investigational clinical drug supply across the AnaptysBio p
-
VP, Pharmacology & Toxicology
We are seeking a head of Pharmacology/Toxicology to lead a team in executing early clinical drug development activities evaluating the pharmacology an
-
Sr. Clinical Study Manager
This position is accountable for all operational activities related to planning, executing/conducting and reporting out of assigned clinical studies i